Savient Pharmaceuticals Inc (NASDAQ:SVNT)
CAPS Rating:
A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.
A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.
Recs
Not profitable - prospects poor. Needs to raise money to survive.